论文部分内容阅读
目的观察尤瑞克林对急性脑梗死患者神经功能的保护作用。方法将200例急性脑梗死患者随机分为观察组和对照组各100例。对照组仅使用依达拉奉治疗,观察组在对照组基础上加用尤瑞克林,其他常规治疗方法一致。比较2组治疗前后NIHSS和mRS评分。结果治疗前,2组NIHSS和mRS评分差异无统计学意义(P>0.05)。经过治疗后,2组NIHSS评分和mRS评分均明显低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.01)。结论尤瑞克林可以很好的改善急性脑梗死患者的神经功能,值得临床推广应用。
Objective To observe the protective effects of uracil on neurological function in patients with acute cerebral infarction. Methods 200 cases of acute cerebral infarction were randomly divided into observation group and control group of 100 cases. The control group only treated with edaravone, the observation group in the control group based on the use of uracil, other conventional treatment methods. NIHSS and mRS scores were compared between the two groups before and after treatment. Results Before treatment, there was no significant difference in NIHSS and mRS scores between the two groups (P> 0.05). After treatment, the NIHSS scores and mRS scores of two groups were significantly lower than before treatment, and the observation group was lower than the control group, the difference was statistically significant (P <0.01). Conclusion Urelin can improve the neurological function of patients with acute cerebral infarction, which is worthy of clinical application.